AI-Enabled Cervical Cancer Screeners

FemTech Startup MobileODT Gets $2.3 Million Grant from NCI

MobileODT, a health tech company known for its revolutionary digital cervical screening product, has been awarded a Small Business Innovation Research Authority grant of $2.3 million. Presented by the United States National Cancer Institute (NCI), the new grant functions as a tribute to the company's advances of MobileODT; a product that is contributing to reducing the prevalence of cervical cancer and the suffering associated with it.

For those unfamiliar, MobileODT is a Tel Aviv-based startup that uses smartphone technology and machine learning algorithms to screen for cervical cancer. The product arrives in the form of a portable "smart" colposcope half the size of a traditional smartphone. Physicians can use the device to take a photo of a woman's cervix, which it then transmits to the cloud, where the company's AI can scan for abnormalities.

Image Credit: MobileODT

AI-enabled Cervical Cancer Screening
The integration of AI into cervical cancer screening devices creates opportunities for faster and more accurate diagnoses, as well as reduced healthcare costs.
Femtech Advancements
FemTech startups like MobileODT that introduce innovative health products tailored to women's healthcare needs will continue to disrupt the healthcare industry.
Smartphone-integrated Medical Devices
Smartphone applications that seamlessly integrate with medical devices to provide accessible and efficient healthcare services will reshape the healthcare industry.

Sectors Adopting This

Health Tech
The continued development of innovative and affordable health monitoring technologies will be key determining factors in the future of the industry.
Machine Learning
ML algorithms in healthcare will lead to the development of new healthcare tools and treatment methods, offering cheaper, faster, and more personalized healthcare services to patients.
Femtech
Startups operating in FemTech will continue to challenge conventional healthcare systems by building products that cater to underrepresented needs in women's healthcare.
SCORE
3.7 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America
GENERATION
  • Gen Alpha
  • Gen Z (primary audience)
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 47%
Activity 51%
Freshness 12%